Zobrazeno 1 - 10
of 225
pro vyhledávání: ''
Publikováno v:
European Neuropsychopharmacology. 44:S25-S26
Publikováno v:
European Neuropsychopharmacology. 40:S473-S474
Publikováno v:
European Neuropsychopharmacology. 40:S182-S183
Autor:
Oleg S. Chaban, Celine Gruget, Christian de Bodinat, Antti Ahokas, A. Avedisova, F. Picarel-Blanchot, Marek Jarema, Dan J. Stein, Valérie Olivier, Livia Vavrusova
Publikováno v:
European Neuropsychopharmacology. 27:526-537
Agomelatine is efficacious in reducing symptoms and preventing relapse in placebo-controlled trials in generalised anxiety disorder (GAD). Nevertheless, fixed dose studies of agomelatine in GAD have not been undertaken. To determine the minimally eff
Publikováno v:
European Neuropsychopharmacology. 29:S410
Autor:
Wiesław Jerzy Cubała, Rosanne Lane, H. Li, I. Divacka, Wayne C. Drevets, P. Molero, Madhukar H. Trivedi, Husseini K. Manji, Yun Zhang, Andrea Fagiolini, X. Li, Michael E. Thase, Pierre Blier, Andrew Winokur, David Hough, A. Janik, István Bitter, A.R. Duca, Richard C. Shelton, Ella Daly, Jaskaran Singh, John Zajecka
Publikováno v:
European Neuropsychopharmacology. 29:S92
Publikováno v:
European Neuropsychopharmacology. 27:S1055-S1056
Autor:
Michelle M. Solleveld, Paul J. Lucassen, H.K. Baek, L. Reneman, E.J.W. van Someren, Marco A. Bottelier, R.M. Rijsman, Anouk Schrantee
Publikováno v:
European Neuropsychopharmacology. 27:S1111-S1112
Publikováno v:
European Neuropsychopharmacology. 27:S1050
Autor:
Trisha Suppes, Josephine Cucchiaro, Yongcai Mao, Robert Silva, Caroline Streicher, Antony Loebel, Andrei Pikalov
Publikováno v:
European Neuropsychopharmacology. 25:S391-S392